APO-Metformin (2020-06-12)Health ProductsJun 12th, 2020 @ 12:00 AM
Basic Details
Issue: Product Safety
Category: Drugs
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Alert type: Drug Recall
Hazard classification: Type I
Summary
Product
APO-Metformin 500 mg Extended Release Tablet
Products
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|---|---|---|---|---|
| PK3968 |
| APO-Metformin 500 mg Extended Release Tablet | DIN 02305062 | Tablet (Extended Release) | Metformin hydrochloride 500 mg |
Reason
Affected lots contain or may contain the presence of N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.
Depth of distribution
Wholesalers, Retailers
For more information
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.